Probiotic and synbiotic safety in infants under two years of age
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
In this study, we systematically evaluated safety aspects in clinical trials with probiotics and synbiotics in young infants (0-2 years of age). This study is an update of earlier reports and covers the recent literature from 2008-2013. The safety evaluation is performed along the Common Terminology Clinical Adverse Events (CTCAE) version 4.0 scale, hereby also providing guidance for future studies. Safety aspects are represented and related to number of participants per probiotic strain/culture, study duration, dosage, clinical condition and selected afflictions. The results show a deficiency in the precise reporting and classification of adverse events in most studies. Analysis of 57 clinical trials with probiotics and synbiotics in combination with eight follow-up studies indicate that probiotic administration to infants between 0 and 24 months is safe with regard to the evaluated strains in infants with a particular health status or susceptibility. Most adverse events and serious adverse events were considered unrelated to the study product, and there were no major safety concerns. Almost all studies concluded that none of the adverse effects were related to the study product; the study products are generally well tolerated. Finally, inconsistent, imprecise and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations and reported outcomes, greatly limit the generalizability of conclusions and argue convincingly for obligatory and standardised behaviour on adverse events (CTCAE) reporting in ‘food’ studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710 · cited 1×
“The intestinal microbiota further matures by close contact with the environment and breast milk (Clemente et al., 2012).”
BackgroundSafety assessment of probiotics for human use
Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G., & Huys, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12127 · Cited by 816
Probiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776 · cited 2×
“There were only 27 reports of fungemia when the yeast S. boulardii concurrently was administered, and the authors concluded probiotics are safe but results cannot be generalised for other or new/future strains (Boyle et al. , 2006).”
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741 · cited 1×
“Additionally, meta-analyses indicate that probiotic supplementation results in a reduction in diarrhoeal duration as well as a reduced incidence of Clostridium difficile induced diarrhoea (Goldenberg et al., 2013; Sanders et al., 2013).”
Lin, H.-C., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H., & Su, B.-H. (2008) · Pediatrics · doi:10.1542/peds.2007-3007 · Cited by 506 · cited 1×
“…such as preterms and infants suffering from diarrhoea, results are more promising; probiotics seem to prevent NEC (Bell’s stage II and higher) and reduce the duration and hospitalisation in diarrhoea (Fernández-carrocera et al., 2012; Grandy et al., 2010; Lin et al., 2008; Teran et al., 2009).”
An update on the use and investigation of probiotics in health and disease
Sanders, M. E., Guarner, F., Guerrant, R., Holt, P. R., Quigley, E. M., Sartor, R. B., Sherman, P. M., & Mayer, E. A. (2013) · Gut · doi:10.1136/gutjnl-2012-302504 · Cited by 503 · cited 2×
“This might be attributable to different study populations (and power of the study) and conditions, probiotic strains, dosage and study duration (Sanders et al., 2013).”
BackgroundSelf-citationSalminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 1×
“!) evaluating 89 cases of Lactobacillus bacteraemia (unrelated to probiotic intake) treatment with antimicrobials was effective both in vitro and in reducing mortality (odds ratio = 0.22; Salminen et al. , 2004).”
InfluentialTwo cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome
Kunz, A. N., Noel, J. M., & Fairchok, M. P. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200404000-00017 · Cited by 319 · cited 1×
“Indeed, bacteraemia was reported in 3 infants with short-bowel syndrome after ingestion of L. rhamnosus GG (De Groote et al., 2005; Kunz et al., 2004).”
De Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P., & Pace, N. R. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154588.79356.e6 · Cited by 284
Coccorullo, P., Strisciuglio, C., Martinelli, M., Miele, E., Greco, L., & Staiano, A. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.066 · Cited by 209
Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis
van der Aa, L. B., van Aalderen, W. M. C., Heymans, H. S. A., Henk Sillevis Smitt, J., Nauta, A. J., Knippels, L. M. J., Ben Amor, K., Sprikkelman, A. B., & the Synbad Study Group (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02416.x · Cited by 172 · cited 1×
“…follow-up study by Luoto et al. (2010) reported no AEs or any effect on growth pattern and development of obesity by L. rhamnosus GG. Van der Aa et al. (2011) demonstrated that, after a follow-up period of one year, infants receiving B. breve M-16V had less asthma-like symptoms compared to…”
Mohan, R., Koebnick, C., Schildt, J., Mueller, M., Radke, M., & Blaut, M. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318181b7fa · Cited by 165
Effect of formula composition on the development of infant gut microbiota
Hascoët, J., Hubert, C., Rochat, F., Legagneur, H., Gaga, S., Emady‐Azar, S., & Steenhout, P. G. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182105850 · Cited by 121
Allen, S. J., Jordan, S., Storey, M., Thornton, C. A., Gravenor, M., Garaiova, I., Plummer, S. F., Wang, D., & Morgan, G. (2010) · The Journal of Nutrition · doi:10.3945/jn.109.117093 · Cited by 119 · cited 1×
“Nevertheless, Allen et al. (2010) observed a higher frequency of lower respiratory tract infections when exposed to a probiotic mixture of L. salivarius CUL61, L. paracasei CUL08, Bifidobacterium animalis subsp. lactis CUL34 and B. bifidum CUL20.”
Soh, S. E., Ong, D. Q. R., Gerez, I., Zhang, X., Chollate, P., Shek, L. P.-C., Lee, B. W., & Aw, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.020 · Cited by 78
Cited by
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
Probiotic supplements might not be universally-effective and safe: A review
Kothari, D., Patel, S., & Kim, S.-K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.104 · Cited by 445
Are Probiotic Really Safe for Humans?
ZAWISTOWSKA-ROJEK, A., & TYSKI, S. (2018) · Polish Journal of Microbiology · doi:10.21307/pjm-2018-044 · Cited by 153
Flach, J., van der Waal, M. B., van den Nieuwboer, M., Claassen, E., & Larsen, O. F. A. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1334624 · Cited by 131
“Probiotic administration is generally recognized as safe (Borriello et al., 2003; Van den Nieuwboer et al., 2014a; Van den Nieuwboer et al., 2014b; Van den Nieuwboer et al., 2015; FDA, 2016) and a reduced risk for antibiotic-associated diarrhea (AAD), necrotizing enterocolitis (NEC) and…”
BackgroundProbiotic use in at-risk populations
Sanders, M. E., Merenstein, D. J., Ouwehand, A. C., Reid, G., Salminen, S., Cabana, M. D., Paraskevakos, G., & Leyer, G. (2016) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.07.001 · Cited by 129
Metadata
- Authors
- van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F., & Brummer, R. J.
- Venue
- Beneficial Microbes
- Publisher
- Walter de Gruyter GmbH
- Published
- 2014-03-01
- Volume
- 5
- Issue
- 1
- Pages
- 45-60
- ISSN
- 1876-2883 (ISSN-L)
- 1876-2891
- OpenAlex
- W2118928270
- Cited by
- 79
- References
- 15
- FWCI
- 15.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.